Product | IL-27 Antibody |
Cat# | 100-12-20A |
Unit/Weight | 100 μg |
Unit Price | $266.00 |
Species Reactivity | H, M |
Tested Application(s) | E, WB |
Brief Description | (IN) Interleukin 27 induce tumor-specific anti-tumor activity mediated through CD8+ T-cells, IFN-gamma, and T-bet. |
Specific Description | Like interleukin-23 (IL-23), IL-27 is a recently discovered member of the IL-6/IL-12 family of proinflammatory and immunoregulatory cytokines. It exists as a heterodimer composed of the p40-related protein EBI3 and an IL-12 p35-related protein termed p28. IL-27 is produced after activation by antigen-presenting cells and induces proliferation of na飗e but not memory CD4+ T-cells. It acts by binding to its receptor WSX-1 and gp130 which results in the activation of a Jak/STAT signaling cascade, suggesting the IL-27 is involved in the regulation of immune processes. It has been suggested that IL-27 can also be used as a therapeutic agent against cancer as it can also induce tumor-specific anti-tumor activity mediated through CD8+ T-cells, IFN-gamma, and T-bet. |
Storage | IL-27 antibody can be stored at 4°C, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures. |
Peptide synthesis/Peptide Library Synthesis/Peptide Modification/Antibody Preparation Eve He eve@pepmic.com www.pepmic.com
2018年9月17日星期一
IL-27 Antibody
订阅:
博文评论 (Atom)
没有评论:
发表评论